Article

MedPointe to sell drug for itchy, allergic eyes

Somerset, NJ-MedPointe Inc. has acquired all U.S. and Canadian rights to azelastine HCl (Optivar), a treatment for itching of the eye associated with allergic conjunctivitis in adults and children ages 3 and older.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
Related Content
Doctors warn TikTok & Instagram reels may be damaging eyes long-term
April 4th 2025

Doctors warn TikTok & Instagram reels may be damaging eyes long-term

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Avisi Technologies releases 6-month interim results from VITA trial
April 4th 2025

Avisi Technologies releases 6-month interim results from VITA trial

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Methylphenidate may impact corneal cells in children with ADHD
April 3rd 2025

Methylphenidate may impact corneal cells in children with ADHD

Myopia onset predicted by accelerated eye changes a year in advance
April 2nd 2025

Myopia onset predicted by accelerated eye changes a year in advance

© 2025 MJH Life Sciences

All rights reserved.